67 related articles for article (PubMed ID: 34512731)
1. Circulating cell-free messenger RNA enables non-invasive pan-tumour monitoring of melanoma therapy independent of the mutational genotype.
Albrecht LJ; Höwner A; Griewank K; Lueong SS; von Neuhoff N; Horn PA; Sucker A; Paschen A; Livingstone E; Ugurel S; Zimmer L; Horn S; Siveke JT; Schadendorf D; Váraljai R; Roesch A
Clin Transl Med; 2022 Nov; 12(11):e1090. PubMed ID: 36320118
[TBL] [Abstract][Full Text] [Related]
2. cfRNAs as biomarkers in oncology - still experimental or applied tool for personalized medicine already?
Kolenda T; Guglas K; Baranowski D; Sobocińska J; Kopczyńska M; Teresiak A; Bliźniak R; Lamperska K
Rep Pract Oncol Radiother; 2020; 25(5):783-792. PubMed ID: 32904167
[TBL] [Abstract][Full Text] [Related]
3. Decoding cell-type contributions to the cfRNA transcriptomic landscape of liver cancer.
Safrastyan A; Zu Siederdissen CH; Wollny D
Hum Genomics; 2023 Oct; 17(1):90. PubMed ID: 37798661
[TBL] [Abstract][Full Text] [Related]
4. Plasma Cell-free RNA Signatures of Inflammatory Syndromes in Children.
Loy CJ; Servellita V; Sotomayor-Gonzalez A; Bliss A; Lenz J; Belcher E; Suslovic W; Nguyen J; Williams ME; Oseguera M; Gardiner MA; ; ; Choi JH; Hsiao HM; Wang H; Kim J; Shimizu C; Tremoulet A; Delaney M; DeBiasi RL; Rostad CA; Burns JC; Chiu CY; Vlaminck I
medRxiv; 2024 Mar; ():. PubMed ID: 38496479
[TBL] [Abstract][Full Text] [Related]
5. A Comprehensive Review on Circulating cfRNA in Plasma: Implications for Disease Diagnosis and Beyond.
Zhong P; Bai L; Hong M; Ouyang J; Wang R; Zhang X; Chen P
Diagnostics (Basel); 2024 May; 14(10):. PubMed ID: 38786343
[TBL] [Abstract][Full Text] [Related]
6. Follicular carcinoma of the thyroid with a single metastatic lesion in the lumbar spine: A case report.
Chen YK; Chen YC; Lin WX; Zheng JH; Liu YY; Zou J; Cai JH; Ji ZQ; Chen LZ; Li ZY; Chen YX
World J Clin Cases; 2022 Sep; 10(26):9493-9501. PubMed ID: 36159419
[TBL] [Abstract][Full Text] [Related]
7. Treating the patient with differentiated thyroid cancer with thyroglobulin-positive iodine-131 diagnostic scan-negative metastases: including comments on the role of serum thyroglobulin monitoring in tumor surveillance.
Fatourechi V; Hay ID
Semin Nucl Med; 2000 Apr; 30(2):107-14. PubMed ID: 10787191
[TBL] [Abstract][Full Text] [Related]
8. Detection of residual and recurrent differentiated thyroid carcinoma by serum thyroglobulin measurement.
Spencer CA; LoPresti JS; Fatemi S; Nicoloff JT
Thyroid; 1999 May; 9(5):435-41. PubMed ID: 10365673
[TBL] [Abstract][Full Text] [Related]
9. A Multiplex Thyroid-Specific Assay for Quantification of Circulating Thyroid Cell-Free RNA in Plasma of Thyroid Cancer Patients.
Yang SP; Koh LCW; Kong KW; Parameswaran R; Loke KSH; Ngiam KY; Tan WB; Loh T; Ng DCE; Goh BC; Ngeow J; Tai ES
Front Genet; 2021; 12():721832. PubMed ID: 34512731
[TBL] [Abstract][Full Text] [Related]
10. Undetectable thyroglobulin after total thyroidectomy in patients with low- and intermediate-risk papillary thyroid cancer--is there a need for radioactive iodine therapy?
Ibrahimpasic T; Nixon IJ; Palmer FL; Whitcher MM; Tuttle RM; Shaha A; Patel SG; Shah JP; Ganly I
Surgery; 2012 Dec; 152(6):1096-105. PubMed ID: 23158181
[TBL] [Abstract][Full Text] [Related]
11. Transient early increase in thyroglobulin levels post-radioiodine ablation in patients with differentiated thyroid cancer.
Stevic I; Dembinski TC; Pathak KA; Leslie WD
Clin Biochem; 2015 Jul; 48(10-11):658-61. PubMed ID: 25895485
[TBL] [Abstract][Full Text] [Related]
12. Post-operative stimulated thyroglobulin and neck ultrasound as personalized criteria for risk stratification and radioactive iodine selection in low- and intermediate-risk papillary thyroid cancer.
Orlov S; Salari F; Kashat L; Freeman JL; Vescan A; Witterick IJ; Walfish PG
Endocrine; 2015 Sep; 50(1):130-7. PubMed ID: 25792004
[TBL] [Abstract][Full Text] [Related]
13. Utility of thyroglobulin measurements in fine-needle aspirates of space occupying lesions in the thyroid bed after thyroid cancer operations.
Suh YJ; Son EJ; Moon HJ; Kim EK; Han KH; Kwak JY
Thyroid; 2013 Mar; 23(3):280-8. PubMed ID: 22950788
[TBL] [Abstract][Full Text] [Related]
14. Serial post-surgical stimulated and unstimulated highly sensitive thyroglobulin measurements in low- and intermediate-risk papillary thyroid carcinoma patients not receiving radioactive iodine.
Kashat L; Orlov S; Orlov D; Assi J; Salari F; Walfish PG
Endocrine; 2016 Nov; 54(2):460-466. PubMed ID: 27189148
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
